- $3.42bn
- $4.21bn
- $1.25bn
- 55
- 17
- 96
- 57
Annual income statement for Envestnet, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 900 | 998 | 1,187 | 1,240 | 1,246 |
| Cost of Revenue | |||||
| Gross Profit | 621 | 692 | 763 | 771 | 773 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 916 | 979 | 1,146 | 1,306 | 1,450 |
| Operating Profit | -16.1 | 19.4 | 40.5 | -66 | -204 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -48.1 | -8.04 | 20.4 | -78.4 | -233 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -17.2 | -2.64 | 12.7 | -85.5 | -246 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -16.8 | -3.11 | 13.3 | -80.9 | -239 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -16.8 | -3.11 | 13.3 | -80.9 | -239 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.456 | 0.628 | 0.65 | -0.739 | -1.4 |